Home > Browse Research > Life Sciences > Pharmaceuticals > Therapeutic Area > Endocrinology/Metabolics

Endocrinology/Metabolics: market research reports

Endocrinology is the branch of medicine dealing with endocrine and metabolic disorders. The endocrine system is made of hormone producing glands, such as the thyroid, parathyroid, pancreas, ovaries, testes, adrenals, pituitary, and hypothalamus. These hormones control reproduction, metabolism, and growth and development.
Endocrinologists are specially trained doctors in treating hormone imbalances and problems.
Most endocrine disorders are chronic and need continuous treatment. Some commonly treated endocrine disorders include diabetes mellitus, thyroid and hyperparathyroid disorders, and osteoporosis. Some less common but serious endocrine disorders include, but are not limited to: Addison’s disease, Cushing’s syndrome, pheochromocytoma, and disorders of sexual development.
In the United States, the most common endocrine disease is diabetes mellitus. Diabetes mellitus is a group of diseases categorized by a deficiency in insulin production or the ability of the body to use it. According to the American Diabetes Association, in 2010, 25.8 million children and adults in the United States (8.3% of the population) have diabetes. The study and treatment of diabetes has made endocrinology/metabolics one of the most in-demand and important medical sects.

Endocrinology/Metabolics market research reports and industry analysis

Other Metabolic Disorders – Pipeline Review, H2 2012 12/26/2012 \| published by: Global Markets Direct ... development for Other Metabolic disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Other Metabolic disorders. Other Metabolic disorders - ... \| more... Search inside this report	$2,000.00
Neuroendocrine Tumors Drug Pipeline Update 2012 10/16/2012 \| published by: BioSeeker Group AB ... Neuroendocrine Tumors Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 54 different targets. These targets are further categorized on in the ... \| more...	$2,270.00
Global Human Growth Hormone Market Report: 2012 Edition 10/1/2012 \| published by: Koncept Analytics ... hormones. It is a pea sized gland situated at the base of brain and is a major component of human body as it expedites the response towards the surrounding environment and settings. Any deformity or ... \| more... Search inside this report	$800.00
Metabolic Partnering Terms and Agreements 9/1/2012 \| published by: Current Partnering ... analysis of how and why companies enter metabolic partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors metabolic technology. ... \| more... Search inside this report	$2,695.00
Growth Disorders – Pipeline Review, H2 2012 8/31/2012 \| published by: Global Markets Direct ... for Growth Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Growth Disorders. 'Growth Disorders - Pipeline Review, H2 2012' ... \| more... Search inside this report	$2,000.00
Future Horizons in the Global Endocrine Function Diagnostics Market: US, Europe, Japan Test Volume and Sales Forecasts by Country and Market Segment 8/30/2012 \| published by: Venture Planning Group ... and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new ... \| more...	$7,500.00
Human Growth Hormone Drugs 8/1/2012 \| published by: Global Industry Analysts ... for the period 2009 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 37 companies including many key and niche players such as Eli Lilly and Company, Ferring Pharmaceuticals ... \| more...	$4,200.00
Market and Product Forecasts: HER2-Negative/Hormone Receptor-Positive Breast Cancer - Patent expiries and novel drugs shape the market in the next decade 7/19/2012 \| published by: Datamonitor ... of novel targeted drugs will help shape the market in the next decade, but little change is anticipated in the overall market value. Features and benefits Analysis of HER2-negative/hormone receptor-positive breast cancer drugs in the ... \| more... Search inside this report	$11,400.00
Global Breast Cancer Drugs Market 2011-2015 7/19/2012 \| published by: Infiniti Research Limited ... of breast cancer worldwide. The Global Breast Cancer Drugs market has also been witnessing the trend of the emergence of combination therapies to treat breast cancer effectively. However, the availability of alternative treatment methods could ... \| more... Search inside this report	$1,500.00
Other Metabolic Disorders Global Clinical Trials Review, H1, 2012 6/30/2012 \| published by: GlobalData ... provides elemental information and data relating to the clinical trials on Other Metabolic Disorders. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the ... \| more... Search inside this report	$2,500.00
Human Growth Hormone Market Forecast to 2015 6/1/2012 \| published by: RNCOS ... holds tremendous growth potential and is estimated to cross the US$ 143 Billion-mark by 2015-end. The market for HGH has expanded greatly in the past few years due to increase in the number of approved ... \| more... Search inside this report	$400.00
Growth Hormone Deficiency Global Clinical Trials Review, H1, 2012 4/30/2012 \| published by: GlobalData ... provides elemental information and data relating to the clinical trials on Growth Hormone Deficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the ... \| more... Search inside this report	$1,000.00
2012 Global Endocrine Function Testing Market Outlook: Growth Opportunities and Strategies 4/18/2012 \| published by: Venture Planning Group ... and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new ... \| more...	$7,500.00
Global Human Growth Hormone Drugs Market 2011-2015 4/16/2012 \| published by: Infiniti Research Limited ... in number of people suffering from growth hormone deficiency. The Global Human Growth Hormone Drug market has also been witnessing the use of human growth hormone for anti-ageing remedy. However, the reluctance of physicians to ... \| more... Search inside this report	$1,500.00
The 2012 Endocrine Function Diagnostics Market: US, Europe, JapanTest Volume and Sales Forecasts by Country and Market Segment 3/28/2012 \| published by: Venture Planning Group ... and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new ... \| more...	$7,500.00
Growth Hormone Deficiency – Pipeline Review, H1 2012 3/19/2012 \| published by: Global Markets Direct ... the therapeutic development for Growth Hormone Deficiency, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Growth Hormone Deficiency. 'Growth Hormone ... \| more... Search inside this report	$500.00
Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients 3/1/2012 \| published by: GBI Research ... to 2018-Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients”, which provides insights into the endocrine disease therapeutics market until 2018. The report is built using data and information ... \| more... Search inside this report	$3,500.00
Testosterone Replacement Therapy (TRT) 3/1/2012 \| published by: Global Industry Analysts ... separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for ... \| more...	$4,600.00
Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 1/31/2012 \| published by: GlobalData ... to 2018”. The report is an essential source of information and analysis on the global Growth Hormone Deficiency (GHD) Therapeutics market. The report identifies the key trends shaping and driving the global Growth Hormone Deficiency ... \| more... Search inside this report	$3,995.00
Growth Hormone Deficiency - Pipeline Review, H2 2011 10/26/2011 \| published by: Global Markets Direct ... the therapeutic development for Growth Hormone Deficiency, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Growth Hormone Deficiency. 'Growth Hormone ... \| more... Search inside this report	$500.00
Growth Hormone Deficiency Global Clinical Trials Review, H2 2011 10/11/2011 \| published by: GlobalData ... provides elemental information and data relating to the clinical trials on Growth Hormone Deficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the ... \| more... Search inside this report	$1,000.00
Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 10/3/2011 \| published by: GBI Research ... Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value”, which provides insights into metabolic disease therapeutics marled until 2017. The report is built using data and information sourced ... \| more... Search inside this report	$3,500.00
Hormone Replacement Therapy (HRT) 9/1/2011 \| published by: Global Industry Analysts ... provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets. The report profiles 42 companies including many key and niche players such as Bayer HealthCare Pharmaceuticals, Inc., Besins ... \| more...	$4,200.00
Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011 6/24/2011 \| published by: GlobalData ... provides elemental information and data relating to the clinical trials on Growth Hormone Deficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the ... \| more... Search inside this report	$1,000.00
Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 - Future Therapies for Birth Control and Reproductive Health 5/25/2011 \| published by: Spectra Intelligence ... Contraceptives and Infertility Drugs, 2011-2018 - Future Therapies for Birth Control and Reproductive Health (2nd Edition) the reader will be introduced to an analysis of current product markets, research and development themes, and company activities ... \| more... Search inside this report	$2,815.00

< prev 1 2 3 4 5 next >

Research assistance

Matching geography

Start new browse

Join Alert Me now!

Endocrinology/Metabolics: market research reports

Endocrinology/Metabolics market research reports and industry analysis